Skip to search formSkip to main contentSkip to account menu

Fenoldopam Mesylate

Known as: 6-Chloro-2,3,4,5-tetrahydro-1-(p-hydroxyphenyl)-1H-3-benzazepine-7,8-diol methanesulfonate(salt), Fenoldopam Mesylate [Chemical/Ingredient] 
The mesylate salt form of fenoldopam, a benzazepine derivative with rapid-acting vasodilator activity. Fenoldopam mesylate is a racemic mixture of S… 
National Institutes of Health

Related topics

Related topics

9 relations
1 ML Fenoldopam 10 MG/ML Injection [Corlopam]Congestive heart failureDecreased Blood Pressure [PE]Fenoldopam

Narrower (1)

SKF-82526J

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2005
Review
2005
Effect of Fenoldopam Mesylate in Critically Ill Patients at Risk for Acute Renal Failure is Dose Dependent
Background: Acute renal failure (ARF) is common and difficult to prevent, especially in intensive care unit (ICU) patients with… 
Highly Cited
1998
Highly Cited
1998
The pH-independent release of fenoldopam from pellets with insoluble film coats.
1997
1997
Stereoselective metabolism of fenoldopam and its metabolites in human liver microsomes, cytosol, and slices.
Fenoldopam is a racemic mixture (R-FEN, S-FEN) that is a selective dopamine (DA-1) receptor agonist with pronounced… 
1992
1992
Electrocardiographic changes during acute treatment of hypertensive emergencies with sodium nitroprusside or fenoldopam.
BACKGROUND Electrocardiograms are routinely obtained before and during the acute treatment of hypertensive emergencies, usually… 
1990
1990
Preservation of renal blood flow during hypotension induced with fenoldopam in dogs
The introduction of drugs that could induce hypotension with different pharmacological actions would be advantageous because side… 
1989
1989
Role of dopaminergic and adrenergic receptors in the pathogenesis of arterial lesions induced by fenoldopam mesylate and dopamine in the rat.
Fenoldopam mesylate (FM), a selective, postjunctional, dopaminergic (DA1) vasodilator, causes a novel lesion of large caliber… 
Review
1989
Review
1989
The Role of Dopaminergic Agents and the Dopamine Receptor in Treatment for CHF
Cet article etudie l'opportunite de l'utilisation des substances dopaminergiques dans le traitement de l'insuffisance cardiaque… 
1989
1989
Pathogenesis of Arterial Lesions Induced by Dopaminergic Compounds in the Rat 1
Fenoldopam mesylate (FM), a selective post-junctional dopaminergic (DA1) vasodilator, causes lesions of large caliber splanchnic… 
1988
1988
Hemodynamic, renal, and neurohumoral effects of a selective oral DA1 receptor agonist (fenoldopam) in patients with congestive heart failure.
1984
1984
Determination of fenoldopam (SK&F 82526) and its metabolites in human plasma and urine by high-performance liquid chromatography with electrochemical detection.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)